Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$54.65
1.302.44%
At close: -
$54.65
0.000.00%
After Hours: Dec 20, 4:00 PM EDT
Comments
Loading...
iRadimed (NASDAQ:IRMD) Stock, Analyst Ratings, Price Targets, Forecasts
iRadimed Corp has a consensus price target of $60 based on the ratings of 1 analysts. The high is $60 issued by Roth MKM on August 2, 2024. The low is $60 issued by Roth MKM on August 2, 2024. The 2 most-recent analyst ratings were released by Roth MKM on August 2, 2024 and April 22, 2024, respectively. With an average price target of $62.5 between Roth MKM, there's an implied 14.36% upside for iRadimed Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
1calculated from analyst ratings
Analyst Ratings for iRadimed
Data brought to you by Benzinga APIs
FAQ
What is the target price for iRadimed (IRMD) stock?
The latest price target for iRadimed (NASDAQ:IRMD) was reported by Roth MKM on August 2, 2024. The analyst firm set a price target for $60.00 expecting IRMD to rise to within 12 months (a possible 9.79% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for iRadimed (IRMD)?
The latest analyst rating for iRadimed (NASDAQ:IRMD) was provided by Roth MKM, and iRadimed maintained their buy rating.
When was the last upgrade for iRadimed (IRMD)?
There is no last upgrade for iRadimed
When was the last downgrade for iRadimed (IRMD)?
There is no last downgrade for iRadimed.
When is the next analyst rating going to be posted or updated for iRadimed (IRMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iRadimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iRadimed was filed on August 2, 2024 so you should expect the next rating to be made available sometime around August 2, 2025.
Is the Analyst Rating iRadimed (IRMD) correct?
While ratings are subjective and will change, the latest iRadimed (IRMD) rating was a maintained with a price target of $65.00 to $60.00. The current price iRadimed (IRMD) is trading at is $54.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.